Edwards Lifesciences Corp held its Annual Meeting on May 7, 2024, where all director nominees were elected, the executive officer compensation proposal was approved, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm was ratified, and the Amended and Restated Long-Term Stock Incentive Compensation Program was approved.